Sundrug Co.,Ltd. (TYO:9989)

Sundrug Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	824,663	801,811	751,777	690,462	648,734	634,310
Revenue Growth (YoY)	6.32%	6.65%	8.88%	6.43%	2.27%	2.68%
Cost of Revenue	613,323	597,723	562,457	518,516	492,228	475,760
Gross Profit	211,340	204,088	189,320	171,946	156,506	158,550
Selling, General & Admin	147,714	142,309	133,294	134,492	122,454	120,879
Other Operating Expenses	-	-	-	-	-	325
Operating Expenses	164,996	159,591	148,323	134,495	122,454	121,204
Operating Income	46,344	44,497	40,997	37,451	34,052	37,346
Interest Expense	-278	-164	-32	-36	-9	-6
Interest & Investment Income	208	160	127	125	128	130
Earnings From Equity Investments	-1,182	-1,567	-	-	-	-
Other Non Operating Income (Expenses)	806	908	636	594	563	758
EBT Excluding Unusual Items	45,898	43,834	41,728	38,134	34,734	38,228
Gain (Loss) on Sale of Investments	198	198	-	-	-	-
Gain (Loss) on Sale of Assets	2	-6	21	144	232	119
Asset Writedown	-735	-998	-856	-864	-282	-375
Other Unusual Items	438	540	367	296	-10	-784
Pretax Income	45,801	43,568	41,260	37,710	34,674	37,188
Income Tax Expense	14,052	12,818	12,134	12,007	10,821	11,859
Net Income	31,749	30,750	29,126	25,703	23,853	25,329
Net Income to Common	31,749	30,750	29,126	25,703	23,853	25,329
Net Income Growth	8.20%	5.58%	13.32%	7.76%	-5.83%	6.91%
Shares Outstanding (Basic)	117	117	117	117	117	117
Shares Outstanding (Diluted)	117	117	117	117	117	117
Shares Change (YoY)	0.01%	0.02%	0.01%	0.01%	0.00%	0.02%
EPS (Basic)	271.43	262.90	249.06	219.83	204.02	216.67
EPS (Diluted)	271.43	262.90	249.06	219.82	204.01	216.63
EPS Growth	8.19%	5.56%	13.30%	7.75%	-5.83%	6.89%
Free Cash Flow	10,768	7,713	4,762	12,591	12,857	15,944
Free Cash Flow Per Share	92.06	65.94	40.72	107.68	109.96	136.37
Dividend Per Share	130.000	130.000	114.000	100.000	71.000	70.000
Dividend Growth	6.56%	14.04%	14.00%	40.84%	1.43%	2.94%
Gross Margin	25.63%	25.45%	25.18%	24.90%	24.13%	25.00%
Operating Margin	5.62%	5.55%	5.45%	5.42%	5.25%	5.89%
Profit Margin	3.85%	3.84%	3.87%	3.72%	3.68%	3.99%
Free Cash Flow Margin	1.31%	0.96%	0.63%	1.82%	1.98%	2.51%
EBITDA	64,338	61,779	56,124	49,519	44,261	46,009
EBITDA Margin	7.80%	7.70%	7.47%	7.17%	6.82%	7.25%
D&A For EBITDA	17,994	17,282	15,127	12,068	10,209	8,663
EBIT	46,344	44,497	40,997	37,451	34,052	37,346
EBIT Margin	5.62%	5.55%	5.45%	5.42%	5.25%	5.89%
Effective Tax Rate	30.68%	29.42%	29.41%	31.84%	31.21%	31.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.